5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.49▲ | 2.50▲ | 2.52▼ | 2.53▼ | 2.60▼ |
MA10 | 2.49▲ | 2.53▼ | 2.57▼ | 2.59▼ | 2.49▲ |
MA20 | 2.53▼ | 2.61▼ | 2.64▼ | 2.60▼ | 2.42▲ |
MA50 | 2.59▼ | 2.60▼ | 2.55▼ | 2.38▲ | 2.80▼ |
MA100 | 2.51▲ | 2.43▲ | 2.40▲ | 2.41▲ | 2.78▼ |
MA200 | 2.39▲ | 2.45▲ | 2.46▲ | 2.70▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.019▼ | -0.028▼ | -0.027▼ | 0.048▲ |
RSI | 44.537▼ | 44.564▼ | 44.838▼ | 49.291▼ | 48.471▼ |
STOCH | 31.944 | 13.763▼ | 14.319▼ | 31.828 | 73.393 |
WILL %R | -72.222 | -79.592▼ | -82.705▼ | -70.732 | -36.000 |
CCI | 28.180 | -62.646 | -89.007 | -121.296▼ | 42.491 |
Wednesday, June 11, 2025 05:30 AM
Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...
|
Thursday, May 08, 2025 05:37 PM
Lisata Therapeutics Inc (NASDAQ:LSTA) reported a decrease in operating expenses by 11.4% year-over-year, indicating effective cost management. The company has made significant progress in ...
|
Thursday, May 08, 2025 01:05 PM
BASKING RIDGE, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 2.49 | 2.51 | 2.49 | 2.51 | 3,560 |
13/06/25 | 2.52 | 2.61 | 2.39 | 2.495 | 17,786 |
12/06/25 | 2.56 | 2.5644 | 2.50 | 2.5588 | 8,405 |
11/06/25 | 2.59 | 2.59 | 2.43 | 2.46 | 11,799 |
10/06/25 | 2.58 | 2.67 | 2.58 | 2.64 | 13,336 |
09/06/25 | 2.69 | 2.74 | 2.58 | 2.6346 | 12,562 |
06/06/25 | 2.7485 | 2.7491 | 2.69 | 2.69 | 2,149 |
05/06/25 | 2.69 | 2.72 | 2.65 | 2.65 | 7,394 |
04/06/25 | 2.59 | 2.75 | 2.59 | 2.66 | 8,605 |
03/06/25 | 2.6955 | 2.78 | 2.6001 | 2.6032 | 5,830 |
|
|
||||
|
|
||||
|
|